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ABSTRACT 
 
 
Objectives: To report Somatosensory Evoked Potentials (SEPs) and Central Motor 
Conduction Times (CMCT) in children with dystonia and to test the hypothesis that these 
parameters predict outcome from Deep Brain Stimulation (DBS). 
Methods: 180 children with dystonia underwent assessment for Globus pallidus internus 
(GPi) DBS, mean age 10 years (range 2·5-19). CMCT to each limb was calculated using 
Transcranial Magnetic Stimulation.  Median and posterior tibial nerve SEPs were 
recorded over contralateral and midline centro-parietal scalp. Structural abnormalities 
were assessed with cranial MRI. One-year outcome from DBS was assessed as 
percentage improvement in Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS-m). 
Results:  Abnormal CMCTs and SEPs were found in 19% and 47% of children 
respectively and were observed more frequently in secondary than primary dystonia.  Of 
children proceeding to DBS, better outcome was seen in those with normal (n=78/89) 
versus abnormal CMCT (n=11/89) (p=0·002) and those with normal (n=35/51) versus 
abnormal SEPs (n=16/51) (p=0·001). These relationships were independent of dystonia 
aetiology and cranial MRI findings. 
Conclusions:  CMCTs and SEPs provide objective evidence of motor and sensory 
pathway dysfunction in children with dystonia and relate to DBS outcome. 
Significance: CMCTs and SEPs can contribute to patient selection and counselling of 
families about potential benefit from neuromodulation for dystonia. 
 
 
 
 
Keywords:  Dystonia; Secondary; Deep Brain Stimulation; Central Motor Conduction 
Time; Somatosensory Evoked Potentials; Dystonic Cerebral Palsy, Children. 
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Highlights 
 
1. A high proportion (47%) of children with dystonia have evidence of abnormal 
sensory pathway function. 
 
2. Central motor conduction times (CMCTs) and somatosensory evoked potentials 
(SEPs) show a significant relationship with deep brain stimulation (DBS) 
outcome, independent of aetiology or cranial MRI. 
 
3. CMCTs and SEPs can guide patient selection and help counsel families about 
potential benefit of DBS. 
 
 
 
Abbreviations 
CMCT = Central Motor Conduction Time 
SEP = Somatosensory Evoked Potential 
DBS = Deep Brain Stimulation 
CP = Cerebral Palsy 
BFMDRS-m = Burke-Fahn-Marsden Dystonia Rating Scale motor score 
HIE = Hypoxic Ischemic Encephalopathy 
COPM-p = Canadian Occupational Performance Measure-performance 
TMS = Transcranial Magnetic Stimulation 
MEP = Motor Evoked Potential 
MRI = Magnetic Resonance Imaging 
CST = Corticospinal Tract 
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1. INTRODUCTION 
The benefits of Deep Brain Stimulation (DBS) of the Globus Pallidus internus (GPi) for 
isolated idiopathic or genetic (formerly termed primary) dystonia are now well 
recognised in both adults and children, with improvements of 52-88% being seen in the 
Burke-Fahn-Marsden Dystonia Rating Scale motor score (BFMDRS-m)(Coubes et al. , 
2004, Vidailhet et al. , 2005, Zorzi et al. , 2005, Alterman et al. , 2007). However, 
isolated dystonia, in which the dystonic movements are the only feature of the 
neurological disease and structural neuroimaging is normal, is rare, especially in 
childhood (Roubertie et al. , 2002). Much more common are the acquired (formerly 
termed secondary) dystonias, in which the movement disorder arises from a neurological 
disease processes or brain insult.  These may be further divided into those arising from 
static lesions (e.g. following hypoxic ischemic encephalopathy (HIE), extreme 
prematurity, infection, a metabolic disturbance or vascular event) and those due to 
degenerative disorders. There are growing reports of children with acquired dystonia, 
such as dyskinetic cerebral palsy (CP) arising from perinatal brain injury, benefitting 
from DBS (Coubes et al. , 2004, Eltahawy et al. , 2004, Zorzi et al. , 2005, Alterman et al. 
, 2007, Katsakiori et al. , 2009, Vidailhet et al. , 2009, Air et al. , 2011, Marks et al. , 
2011, Gimeno et al. , 2013a, Koy et al. , 2013, Lumsden et al. , 2013b, Marks et al. , 
2013, Olaya et al. , 2013, Romito et al. , 2015). These children respond more modestly, 
with mean improvement in BFMDRS usually less than 25% (Coubes et al. , 2004, 
Eltahawy et al. , 2004, Zorzi et al. , 2005, Alterman et al. , 2007, Katsakiori et al. , 2009, 
Vidailhet et al. , 2009, Marks et al. , 2011, Gimeno et al. , 2013a, Koy et al. , 2013, 
Lumsden et al. , 2013b, Marks et al. , 2013), but the benefits gained can significantly 
enhance the families’ daily lives through improved comfort and daily care (Gimeno et al. 
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, 2012, Gimeno et al. , 2013b, Olaya et al. , 2013, Elze et al. , 2016). Referrals of such 
children are increasing, but outcomes vary significantly across this widely heterogeneous 
population (-7 – 77% change in BFMDRS-m), even within individual studies (e.g. -7 to 
55% reported by Vidailhet et al;(Vidailhet et al. , 2009)  0–40% reported by Olaya et al 
(Olaya et al. , 2013)). This makes it difficult to predict the degree of benefit an individual 
child may gain from neuromodulation (Austin et al. , 2017). Even within the isolated 
dystonia group some DYT1-negative children show little or no response to DBS (Gimeno 
et al. , 2014). Appropriate family counselling is essential to manage expectations before a 
child undergoes functional neurosurgery, which is not without risk (Kaminska et al. , 
2016, Moro, 2016), but predictive markers of DBS outcomes in acquired and complex 
dystonias are lacking (Koy et al. , 2017). Although structural imaging abnormalities on 
cranial MRI are generally associated with less benefit from DBS (Eltahawy et al. , 2004, 
Romito et al. , 2015), outcomes still vary widely, regardless of whether MRI is normal or 
abnormal (Zorzi et al. , 2005, Krause et al. , 2006, Vidailhet et al. , 2009); imaging 
evidence of structural abnormality does not necessarily correlate with function (Lumsden 
et al. , 2015). Somatosensory Evoked Potentials (SEPs) and Central Motor Conduction 
Times (CMCT) have been performed in all children being assessed for possible DBS 
within our service since 2009 and 2007 respectively, to provide objective evidence of 
sensory and motor pathway function. This study reports CMCT and SEP data from a 
cohort of 180 children with dystonia and, for those proceeding to DBS, tests the 
hypothesis that these neurophysiological markers are associated with outcome.  
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2. METHODS 
Data were reviewed from 180 consecutive children (88 female, 92 male) with medically 
refractory dystonia who attended King’s College Hospital between September 2007 and 
September 2015 for CMCT and/or SEPs as part of their assessment for possible pallidal 
Deep Brain Stimulation via the Complex Motor Disorders Service at Evelina London 
Children’s Hospital. CMCT and MRI data from 62 children were reported previously 
(McClelland et al. , 2011). The neurophysiological studies were performed as part of a 
standard clinical work-up, along with detailed imaging and a multi-disciplinary clinical 
assessment by a paediatric neurologist, nurse specialist, physiotherapist, occupational 
therapist, speech and language therapist and clinical psychologist. This was a 
retrospective analysis of data collected via standard clinical practice and thus formal 
ethical approval was not required under NHS research governance arrangements. 
 
2.1 Clinical Assessments 
The children were examined by a consultant paediatric neurologist with expertise in 
movement disorders (JPL). Dystonia was classified in line with previous publications 
(Lin et al. , 2014, McClelland et al. , 2016) and with the Albanese dystonia classification 
(Albanese et al. , 2013), taking into account the clinical characteristics and aetiology 
(Table 1). Dystonia severity was assessed using the BFMDRS-m at baseline. DBS 
outcome was primarily assessed as change in dystonia severity, expressed as percentage 
improvement in BFMDRS-m from baseline to 1 year post-operatively (as used widely in 
the DBS literature). The percentage change has the disadvantage that it tends to under-
estimate improvement for severely affected individuals (i.e. with higher baseline scores), 
and over-estimate improvement for less severely affected individuals.  Therefore the 
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absolute change in BFMDRS was also calculated.  In addition, change in functional 
performance was assessed, using the Canadian Occupational Performance Measure-
performance (COPM-P), a goal-orientated assessment tool which scores the level of 
performance regarding a set of skills and activities, from 1-10 (Gimeno et al. , 2014). A 
two point change is considered clinically significant.   
 
2.2 Neurophysiological recordings 
Data were acquired with a NIHON KODON Neuropack M1 MEB9200 EMG/EP system. 
Electrical stimuli of 0·2millisecond duration were applied at 2·1Hz to the median nerve 
at the wrist or the posterior tibial nerve at the ankle, just above motor threshold. Median 
nerve SEPs were recorded over ipsilateral Erb's point, the 7th and 2
nd
 cervical vertebra 
and contralateral centro-parietal scalp overlying sensory cortex at C3’ and C4’ (2cm 
posterior to C3 and C4). Posterior tibial nerve SEPs were recorded primarily over 
ipsilateral popliteal fossa and midline scalp at Cz’ (2cm posterior to Cz). Fz (mid-frontal) 
was the reference for upper and lower limb recordings. Due to a modification in protocol, 
a more recent sub-group of children also had lower limb SEPs recorded with a Ci - Cc or 
a Cz’ – Cc derivation (where i = ipsilateral and c=contralateral)(Miura et al. , 2003). The 
upper lumbar component was recorded where possible (T12/L1 – iliac crest). Filter band-
pass was 1-500Hz. At least two averages of 250 artefact-free trials were recorded to 
determine reproducibility.   
Analysis focused on the first negative and first positive cortical components. The 
components were labeled according to their polarity and peak-times in adults (equivalent 
to N19 and P25 for upper limb SEPs and to P37 and N45 for lower limb SEPs, see Figure 
1).  Peak-times and central sensory conduction time (cortical to cervical/lumbar 
  
 9 
component inter-peak interval) were compared with published paediatric norms, taking 
into account age and height (Taylor et al. , 1988, Boor et al.  1998a, Boor et al. , 1998b). 
Cortical potentials were classed as abnormal if they were delayed (peak times greater 
than published mean for age-group + 2·5 standard deviations), absent or of abnormal 
waveform (i.e. clear time-locked cortical activity was present but waveforms were poorly 
formed or broadened) (See Figure 1). Technically unsatisfactory recordings were 
excluded from further analysis.   
 
CMCT was assessed using Transcranial Magnetic Stimulation (TMS) and the F-wave 
method and interpreted in relation to established norms, as published previously 
(McClelland et al. , 2011).  CMCT reaches adult values by age 3 years for upper limbs 
(Eyre et al. , 1991)  and by age 6 years for lower limbs (Muller et al. , 1992).  A CMCT 
was considered abnormal if it was prolonged or the MEP to that limb was absent.  For the 
purposes of statistical analysis, any cases in whom a prolonged CMCT was obtained 
which could have been physiological, due to immaturity, were excluded from the analysis 
(see McClelland et al 2011 for discussion). 
For each individual, there were a maximum of 4 limbs of SEP data and 4 limbs of CMCT 
data, but not all children had satisfactory data recorded from all 4 limbs.  Results for 
individual limbs are therefore reported briefly for transparency, but in general the results 
are then simplified by considering the result for an individual child.  For a given child, if 
CMCT to one or more limbs was abnormal, that child was considered in the “abnormal 
CMCT” group.  Likewise, if the cortical SEP from one or more limbs was abnormal, that 
child was considered in the “abnormal SEP” group. 
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2.3 Imaging 
The children underwent MR examination on an Achieva 1·5 Tesla MRI system (Philips, 
Best, Netherlands), under general anaesthesia. Images were acquired using an 8-channel 
head coil, according to the local “DBS protocol”, to include those sequences required by 
the neurosurgeons for electrode targeting in the event that the patient went forward for 
DBS surgery. The sequences included are described previously(McClelland et al. , 2011). 
Recent protocol modification includes a volumetric T1-weighted sequence with axial and 
coronal reformats (replacing coronal and sagittal T1-weighted) and a volumetric proton 
density sequence (replacing the thin axial T1-weighted and dual echo sequence for the 
basal ganglia). The MRI scans were interpreted by a consultant neuroradiologist and the 
findings classified, for the purposes of this study, on the anatomical location of 
abnormalities (See Figure 2), similar to our previous publication (McClelland et al. , 
2011) and based on a modified version of the classifications used by Bax (Bax et al. , 
2006) and Robinson (Robinson et al. , 2009). The rationale was to identify abnormalities 
in the target nucleus (globus pallidus internus) and to identify those patterns of 
abnormality on scan which would be expected to be associated with dysfunction of the 
Corticospinal tract. 
 
2.4 Neurosurgical procedure 
For children proceeding to DBS, surgery was performed under isofluorane general 
anaesthesia in all patients, in view of the young age of the children. Stereotactic MRI was 
performed pre-operatively under anaesthesia with a Leksell G Frame in place to 
determine co-ordinates targeted in the postero-latero-ventral GPi. Bilateral stimulation 
was used in each case. For each side, prior to insertion of the stimulating electrode, 
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single-pass microelectrode data were obtained: the presence or absence of active cells at 
each level assisted in identification of the GPe, medial medullary lamina and GPi, thus 
guiding electrode tip position(Lumsden et al. , 2013a, McClelland et al. , 2016). Once the 
target had been confirmed or amended the microelectrode was withdrawn and the 
stimulating electrode inserted along the same track (quadripolar DBS electrode model 
3389, Medtronic, Minneapolis, MN, USA).  The GPi was the target in all cases except 
two children in whom MRI indicated virtually complete destruction of the globus 
pallidus. The sub-thalamic nucleus was targeted in these two cases.  Final electrode 
placement was confirmed by post-operative stereotactic CT scan, under the same general 
anaesthetic, fused with the intra-operative in-frame pre-surgical MRI. The pulse 
generator was then inserted (Soletra, Kinetra, Activa PC or Activa RC pulse generators, 
Medtronic, Minneapolis, MN, USA). 
 
2.5  Statistical Analysis 
Prior to analysis, our key hypotheses were 1) children with abnormal SEPs show less 
improvement following DBS than those with normal SEPs, 2) children with abnormal 
CMCT show less improvement following DBS than those with normal CMCT.  
Initial data analysis was masked to outcome from DBS.  CMCT and SEP data for each 
individual were then analysed in relation to dystonia aetiology, imaging and DBS 
outcome. Not all children had data for both measures.  For children in whom both CMCT 
and SEP data were available (n=77), the combined results were summarized as follows:  
Both CMCT and SEP normal, Either CMCT or SEP abnormal, Both CMCT and SEP 
  
 12 
abnormal. This allowed evaluation of the secondary hypothesis that children in whom 
CMCT and SEP are both abnormal have worse outcome than those in whom one or 
neither test is abnormal.  
Data analysis was performed in SPSS and R version 3.3.1. Differences in numeric data 
between groups were investigated using Kruskal-Wallis and Mann-Whitney tests for 
percentage change in BFMDRS (non-normally distributed data) and non-paired t-tests for 
COPM scores (approximately normally distributed data). For these three key hypotheses, 
the significance level was set at 0·01. To assess possible confounding, sub-group 
analyses were performed (using a significance level of 0·05) with regards to dystonia 
aetiology (acquired versus idiopathic/genetic dystonia) and imaging findings.  As an 
additional sensitivity analysis for confounding, linear regression models were fitted in a 
data-driven approach (see Supplementary Material for methods).  
 
3. RESULTS 
3.1 CMCT data 
Of 176 children tested, technically satisfactory CMCT data were obtained for 427 limbs 
in 146 children, (age range 2.5–19 years, mean 10·1, SD 4·4) (see Table 1). CMCT 
findings for 58/427 limbs (14%) were abnormal comprising 42 (10%) delayed responses 
and 12 absent MEPs (4%). Twenty-eight children (19%) had an abnormal CMCT result 
(prolonged CMCT or absent MEP) to at least one limb. The distribution of children with 
abnormal CMCTs across the aetiological groups is shown in Fig 2A. Abnormal CMCTs 
were seen in a higher proportion of children with acquired (22%) than idiopathic/genetic 
dystonia (9%) (non-significant trend Fisher’s Exact Test  p=0·088). Of the 
idiopathic/genetic group, abnormal CMCT was seen only in complex idiopathic/genetic 
  
 13 
dystonia and was not seen in isolated idiopathic/genetic dystonia.  
 
Aetiological group 
New classification 
Aetiological group 
Previous 
classification 
Number (%) of 
patients 
with satisfactory 
SEP data  
Number (%) of 
patients 
with satisfactory 
CMCT data  
Isolated Idiopathic / 
Genetic  
Early onset generalised 
isolated dystonia 
Primary 8 (7.8) 
 
(Of whom 5 DYT1 
positive) 
14 (9.6) 
 
(of whom 7 DYT1 
positive) 
Complex Idiopathic / 
Genetic 
Early onset generalised 
dystonia with 
associated features 
(normal cranial MRI) 
Primary Plus 13 (12.7) 
 
(of whom 3 DYT11 
positive and 1 TIFF1 
positive) 
19 (13) 
 
(of whom 2 DYT11 
positive and 1 TIFF1 
positive) 
Acquired non-
degenerative due to 
perinatal brain injury 
 
Secondary static – 
dyskinetic cerebral 
palsy 
50 (49) 68 (46.6) 
Acquired non-
degenerative due to 
metabolic condition 
 
Secondary static – 
metabolic 
7 (6.9) 11 (7.5) 
Acquired non-
degenerative due to 
other cause 
 
Secondary static – 
other cause 
18 (18.6) 24 (16.4) 
Acquired 
Degenerative due to 
Neuronal degeneration 
with Brain Iron 
Accumulation or 
mitochondrial 
Secondary 
progressive 
(Neuronal 
degeneration with 
Brain Iron 
Accumulation or 
mitochondrial) 
 
4 (4.9) 10 (6.8) 
TOTAL  100 146 
Table 1:  Distribution of patients across different aetiological groups.  Only the patients 
with technically satisfactory data are included. 
Footnotes: 1. 100/103 (97%) of children tested for SEPs had technically satisfactory data. 146/174 (84%) 
children tested for CMCT had technically satisfactory data.   
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2. A definition of each group according to both the new dystonia classification(Albanese et al. , 2013) and 
the previous classification used in literature from this group and others is provided to facilitate comparison 
with past and future studies. 
3. The term “dyskinetic cerebral palsy” implies CP dominated by dystonia, choreo-athetosis, or both, according to the 
Surveillance of Cerebral Palsy in Europe Study 2000 (Surveillance of Cerebral Palsy in, 2000).  None of the children in 
this cohort had pure choreo-athetosis without dystonia.  
 
 
3.2 SEP data 
Of 103 children tested, technically satisfactory SEP data were obtained from 368 limbs in 
100 children, age range 2–19 years, mean 9·8, SD 4·4) (See Table 1). Fewer children had 
SEP data than CMCT because SEP testing was introduced to the assessment regimen 
more recently. Cortical potentials from 100/368 limbs (27%) were abnormal, comprising 
47 delayed, 13 absent and 40 responses with abnormal waveform. Almost half of all 
children (47%) showed at least one abnormal cortical potential. The Central 
Sensory Conduction Time could only be calculated in a subset of patients/recordings and, where 
available, confirmed central delay in six responses with delayed cortical peak times. In one 
patient it was normal despite delay in cortical responses. (See Supplementary Material for further 
details).  The distribution of children with abnormal SEPs by aetiology is shown in Fig 
2A. One child with idiopathic isolated dystonia showed apparently prolonged cortical 
peak times from the lower limbs bilaterally compared with age-matched normative 
data,(Boor et al. , 1998a) but that child’s height was above the 99·6th centile for her age 
(148cm; age 8 years), and the SEPs probably show no clinically significant abnormality. 
Abnormal SEPs were seen more often in acquired (53%) than idiopathic/genetic dystonia 
(24%) (Fisher’s Exact Test p=0·017) and were seen most frequently in children with 
dyskinetic CP and in those with acquired degenerative dystonia (due to Neuronal 
Degeneration with Brain Iron Accumulation or mitochondrial disease).  
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3.3 Analysis by imaging sub-group   
The distribution of children with abnormal CMCT and SEP in relation to imaging is 
shown in Fig 2B. Abnormal CMCT and SEPs were identified in children across all 
imaging categories, including those with normal MRI, of whom 8/25 (32%) had 
abnormal SEPs and 3/35 (9%) had abnormal CMCT. Abnormal SEPs and CMCT were 
most frequently present in the children with evidence of periventricular white matter 
damage on MRI. 
 
3.4 Severity Data 
Four children did not proceed to the full assessment and therefore did not have baseline 
BFMDRS-m scores measured.  Severity data were available for 142 children. The 
majority of children’s baseline BFMDRS-m scores exceed 50. The median score was 85 
(range 7-115).   For the cohort as a whole, there was no significant difference in the 
baseline BFMDRS-m scores of those children who proceeded to DBS (n=104, median 
score 83.0) and those who did not (n=38, median score 91.3) (Mann Whitney test 
p=0.163).   
 
3.5 CMCT in relation to DBS dystonia outcome 
Eighty-nine children with CMCT data went forward for DBS and had 1 year outcome 
data available (See Fig. 3A, Fig 4 and Table S1 – Supplementary Material).  There was 
no significant difference in baseline severity for those with normal CMCT (n=78, median 
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score 78.3) versus those with abnormal CMCT (n=11, median score 88.5) (Mann 
Whitney test p=0.407).  However, children with normal CMCT had significantly better 
outcomes than those with abnormal CMCT (Mann Whitney test p=0·002). Sub-group 
analyses showed this relationship was maintained regardless of aetiology or the 
presence/absence of cranial MRI abnormality (Fig. 4B-E).  Statistical significance was 
lost for some sub-groups due to the smaller sample size.  Results were qualitatively 
similar using both percentage and absolute change in BFMDRS-m score. 
 
 
3.6 SEP in relation to DBS dystonia outcome 
Fifty-one children with SEP data proceeded to DBS and had 1 year outcome data 
available. (Fig. 3B, Fig. 5 and Table S1 – Supplementary Material).  There was no 
significant difference in baseline severity for those with normal SEP (n=35, median score 
74.0) versus those with abnormal SEP (n=16, median score 86)(Mann Whitney test 
p=0.094).  However, children with normal SEP had significantly higher outcome scores 
than those with abnormal SEP (Mann Whitney test p=0·001). Sub-group analyses 
showed this relationship was maintained regardless of aetiology or the presence/absence 
of cranial MRI abnormality (Fig. 5B-E).  Statistical significance was lost for some sub-
groups due to the smaller sample size.  Again, results were qualitatively similar using 
both percentage and absolute change in BFMDRS-m score. 
 
3.7 Combined Neurophysiology results in relation to DBS Dystonia Outcome 
Outcome data were available for 40 children with both CMCT and SEP data (Fig 6, Table 
S2 – Supplementary Material). Kruskal-Wallis test showed a significant effect of the 
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Combined Neurophysiology results on outcome (p=0·002). For the four children in 
whom both CMCT and SEP were abnormal, BFMDRS-m scores deteriorated 
substantially following DBS.  Post-hoc Mann Whitney tests showed significantly worse 
outcome for the “both tests abnormal” group compared with the “both tests normal” 
group  (p=0·002) and significantly worse outcome for the “both tests abnormal” group 
versus the “one test abnormal” group (p=0.001). Sub-group analyses again showed that 
this relationship was maintained regardless of aetiology or the presence/absence of 
cranial MRI abnormality (Fig. 6B-E).  Statistical significance was lost for some sub-
groups due to the smaller sample size.  Again, results were qualitatively similar using 
both percentage and absolute change in BFMDRS-m score. 
Outcomes for children receiving STN-DBS 
Two children received STN rather than GPi stimulation, because their MRI indicated virtually 
complete destruction of the globus pallidus.  One had bilateral pallidal necrosis following a febrile 
illness. This child had both normal CMCT and normal SEP and showed a 27% BFMDRS-m 
improvement at 1 year. The second child had methylmalonic acidaemia with MRI showing cystic 
changes to both Globus pallidi. This child had normal CMCT but did not have SEPs recorded (having 
attended our service prior to our including SEP in the assessment). They did not show any 
improvement in BFMDRS-m at 1 year (% change of -2.8%). Inclusion/exclusion of their data from the 
analysis did not make any significant change to the overall results. 
 
 
 
3.8 Multiple Regression analysis 
As an additional check for potential confounding, linear models were fitted with variables 
chosen in a data-driven approach.  The % change in BFMDRS-m score was modelled in 
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relation to dystonia aetiology (acquired versus idiopathic/genetic), cranial MRI (normal 
vs abnormal), CMCT result (normal vs abnormal), and SEP result (normal vs. abnormal). 
Two models were identified that showed similar predictive performance (Table 2). The 
aetiology was always relevant, while either the SEP (model R²=0.353) or CMCT (model 
R²=0.409) was sufficient. Once the aetiology was considered, cranial MRI results no 
longer offered substantial prediction improvements in this model. 
 
Effect 95% CI p 
Model 1 (89 patients with CMCT measurements and BFMDRS outcomes) 
(Intercept) 34.621 [24.126; 45.117] <0.00001 
Acquired dystonia -29.234 [-41.794; -16.673] 0.00002 
SEP abnormal -15.231 [-27.792; -2.671] 0.01850 
Model 2 (51 patients with SEP measurements and BFMDRS outcomes) 
(Intercept) 35.964 [27.741; 44.187] <0.00001 
Acquired dystonia -30.513 [-40.338; -20.689] <0.00001 
CMCT abnormal -16.163 [-29.886; -2.440] 0.02150 
 
Table 2. Two regression models for % change in BFMDRS-m that were created in a 
data-driven approach. A full model containing all covariates is available in the 
Supplementary Material (Table S3). 
 
 
3.9 CMCT and SEP in relation to Functional Performance Outcome (COPM-P)  
One-year post-DBS COPM-P scores for children with normal SEP (n=30, mean score 
3.08 +/- SE 0.34) were higher than those with abnormal SEP (n=16, mean 1·98 +/- SE 
0.30) (Independent samples t-test: p=0·020) (See Figure S1 – Supplementary Material). 
However, there was no difference in COPM-P scores for children with normal versus 
abnormal CMCT (See Figure S2 – Supplementary Material). 
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4. DISCUSSION 
This is the largest reported cohort of neurophysiological findings in children with 
dystonia and the first report to relate clinical neurophysiological parameters to outcome 
from DBS in dystonia. The data reflect the broad spectrum of movement disorders in 
children presenting to a quaternary paediatric neurology service and national 
neurosurgical referral centre for DBS neuromodulation therapy.  
4.1 Key findings 
1. Abnormal CMCT was demonstrated in 19% of children, observed across all groups, 
except for isolated genetic/idiopathic dystonia (Fig. 2). Dystonic disorders are not 
typically associated with dysfunction of the corticospinal tract. However, in many 
children with acquired dystonia imaging findings raise the possibility of corticospinal 
tract disruption. The data support previous findings that most children with dystonia or 
dyskinetic CP have normal CMCT even when imaging changes suggest corticospinal 
tract damage (McClelland et al. , 2011). Many of these children had bilateral lesions on 
MRI and our findings concur with other reports of normal CMCT in children diagnosed 
with bilateral CP (Eyre et al. , 2007, Park et al. , 2014). It is noted that TMS activates 
preferentially the cortico-motoneuronal component of the corticospinal tract(Mills, 1999) 
and CMCT therefore only provides insight into a part of corticospinal tract function. At a 
pragmatic level however, demonstration of intact corticospinal projections is an 
important pre-surgical requirement for DBS neuromodulation (see below). 
2.  Approximately half the children had an abnormal cortical SEP from at least one limb.  
Only one child with idiopathic isolated dystonia had potentially delayed SEPs, which 
were probably height-related in this case. Our data are therefore consistent with adult 
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studies reporting normal cortical SEPs (N20 response) in idiopathic/genetic isolated 
dystonia (Murase et al. , 2000b, Tinazzi et al. , 2000, Frasson et al. , 2001). Abnormal 
cortical SEPs were seen in four children with “complex idiopathic” dystonia, with 
unknown aetiology, no history of brain insult and normal cranial MRI, but in whom there 
was some additional abnormality such as mild learning difficulties.  The finding of an 
abnormal SEP could provide further clues to the underlying pathophysiology in this 
group (see below). The majority of abnormal cortical SEPs occurred in children with 
acquired dystonia, which is not surprising. Abnormal SEPs have been reported in 
children with ‘spastic’(Tomita et al. , 2006, Riquelme et al. , 2014) and athetoid CP 
(Tomita et al. , 2006), but not specifically in dystonic CP or other forms of acquired 
dystonia.  Indeed there is a paucity of published neurophysiological data in children with 
dystonia or dyskinetic cerebral palsy(McClelland, 2017). Dyskinetic CP was the largest 
sub-group in this study, comprising approximately 50% of our total cohort and >60% of 
our acquired dystonia cohort. These data therefore extend scientific knowledge in this 
field.   
3.  Neurophysiological abnormalities were present not only in children with abnormal 
cranial imaging, but also in those with normal imaging.  In the SEP cohort, abnormal 
SEPs were identified in 8/25 children with normal cranial MRI; in the CMCT cohort, 
abnormal CMCTs were identified in 3/35 children with normal cranial MRI.  Imaging 
forms an important part of the assessment of children for DBS but clinical 
neurophysiological parameters are often neglected. The data show that routine 
neurophysiological tools can provide objective evidence of sensory and motor pathway 
disruption even in children whose imaging is normal. This facilitates characterization of 
the disorder, thereby helping to manage the expectations both of the child and the family. 
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Some children had abnormal imaging but normal neurophysiology (Fig. 2B), providing 
an important reminder that MRI provides a marker of underlying structure, but not 
necessarily function.  Imaging and neurophysiology therefore both provide important and 
complementary information.   
4.   The most important clinical finding is the relationship between neurophysiological 
markers and outcome from DBS. Both abnormal CMCT and abnormal SEP are 
associated with poorer outcome, measured with BFMDRS (Figs 4 and 5).  Abnormal 
SEPs were additionally associated with poorer outcome measured with COPM-P. A 
combination of both CMCT and SEP being abnormal was consistently associated with 
very little benefit from DBS and even a deterioration in dystonia severity, albeit with 
very small numbers (N=4, median change -13%; range -12 to -22%).  Although it is 
difficult to exclude all confounding factors, sub-group analyses demonstrated that the 
association between neurophysiology and DBS outcome was independent of dystonia 
aetiology and cranial MRI findings (Figs 4–6). Multiple regression analysis also 
confirmed that the predictive information provided by neurophysiology findings is 
independent of aetiology and MRI.   
 
4.2 Limitations 
1. Clinical data collection was not masked to the patient’s condition.  However, the 
SEP/CMCT findings were interpreted prior to any patient undergoing DBS and so could 
not have been biased with regards to outcome.  The hypotheses for the retrospective 
review were specified prior to the analysis and this analysis was also blinded to outcome 
from DBS.   
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2. Cortical SEPs were recorded only over the standard locations for sensorimotor cortex. 
Re-organisation of sensory cortex could conceivably explain the inability to detect a 
normal cortical response in some individuals with perinatal brain lesions. However, the 
lower limb protocol was amended to assess a wider cortical area two years into the study 
period and continued to identify an increased proportion of abnormal cortical responses 
in the acquired dystonia group.   
3.  Variations in DBS electrode placement were not included in the current analysis.  
Previous analysis of DBS electrode placement in a group of 42 children from our cohort 
found no significant difference in the accuracy of electrode placement between children with 
primary (genetic/idiopathic) dystonia and those with secondary (acquired) dystonia 
(Lumsden et al. , 2013a). Furthermore, Lumsden et al (2013a) found no significant 
correlation between DBS outcome at 1 year and the Euclidean distance between the target 
and the actual electrode position.  However, the possibility of some confounding effect of 
electrode placement on the current results cannot be excluded. 
4.  This is a retrospective analysis of results obtained with current clinical practice. 
Previous theoretical assumptions/implications regarding abnormal CMCT/SEP results 
will have influenced the decision of whether to proceed to DBS (see below), so the 
numbers of children in these groups are relatively small. Nevertheless, even with these 
small numbers, significant differences in outcome were seen between those with normal 
versus abnormal neurophysiology. 
5.  Outcome was assessed primarily as % or absolute improvement in BFMDRS-m score 
at one year.  The limitations of this measure have been raised previously (Gimeno et al. , 
2012, Gimeno et al. , 2014), particularly with regard to acquired dystonias. However, 
while the absolute scores may not reflect accurately the patient’s ability, the scores do 
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correlate with other disability classification scales (Elze et al. , 2016) so the differences in 
benefit observed between those with normal versus abnormal neurophysiological 
parameters are likely to be robust. In addition, COPM-P scores also differed significantly 
with SEP findings.  
6.  Longer term follow-up of the children is still required. Benefits from DBS can 
continue to increase for several years post-implantation, whilst for those patients with 
acquired degenerative dystonias, such as Neuronal degeneration with Brain Iron 
Accumulation or mitochondrial abnormalities, a gradual decline in DBS efficacy is often 
seen.  An on-going longer-term follow up study for these (n=12) and indeed all the 
children who proceeded to DBS is therefore appropriate. 
 
4.3 Interpretation 
Whilst it is not unexpected that a proportion of children in this cohort would show 
neurophysiological abnormalities, the prevalence of sensory pathway abnormalities is 
striking. The finding of greater sensory than motor pathway disruption in the present 
cohort is consistent with diffusion tensor imaging studies that revealed a higher 
proportion of abnormalities in thalamo-cortical sensory than motor pathways in children 
with ‘spastic’ CP and periventricular leukomalacia (Hoon et al. , 2002, Hoon et al. , 
2009). In our cohort, the imaging finding most commonly associated with abnormal SEPs 
was evidence of periventricular white matter damage, therefore extending these 
observations to children with predominantly dyskinetic (rather than spastic) CP. 
Whilst it is not possible to conclude from these data that the sensory abnormalities are 
causal, it is likely that disruption of sensory pathways contributes to the disordered motor 
control in these children.  Several studies have demonstrated anomalous sensory 
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processing in children with “spastic” CP (Riquelme et al. , 2010, Kurz et al. , 2014, 
Riquelme et al. , 2014, Kurz et al. , 2015a) and these abnormalities do appear to have 
functional importance (Kurz et al. , 2015b).  There is clear evidence that primary dystonia 
is a network disorder involving multiple brain regions, including the cerebellum and 
sensorimotor cortex (Neychev et al. , 2011, Neumann et al. , 2015) and is a disorder of 
sensorimotor integration (Hallett, 1995, Tinazzi et al. , 2000, Abbruzzese et al. , 2001, 
Frasson et al. , 2001, Abbruzzese et al. , 2003, Tinazzi et al. , 2003). Reduced pre-
movement gating of incoming sensory information has been demonstrated in adults with 
writer’s cramp (Murase et al. , 2000a), and abnormal cortical plasticity in response to 
afferent stimulation has been demonstrated in adults with idiopathic/genetic isolated 
dystonia (Quartarone et al. , 2008, Tamura et al. , 2009). These abnormalities may lead to 
sensory information being distorted, resulting in abnormal motor output (Frasson et al. , 
2001, Tinazzi et al. , 2003). Although the sensory pathway abnormalities in 
idiopathic/genetic dystonia occur at cortical processing level (e.g. reduced inhibition of 
afferent inputs),(Hallett, 2011) we postulate that in children with dystonia arising from 
other causes, disruption to the sensory system at other nodes of the network may well 
contribute to the disorder. For example disruption of somatosensory pathways arising 
from perinatal brain injury may also lead to abnormal perception of sensory information, 
which in turn leads to a distorted motor output. Indeed, if these abnormalities have been 
present since early life, including within ‘critical’ and ‘sensitive’ windows for 
development (Ismail et al. , 2017), they may disrupt the maturation of normal 
sensorimotor networks and the development of normal motor programmes may never 
occur. The differential outcome for acquired versus isolated idiopathic/genetic dystonia 
certainly suggests that the underlying pathophysiological mechanisms of the movement 
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disorder are likely to be different (Neychev et al. , 2011) and several recent studies have 
provided evidence to this effect (Trompetto et al. , 2012, Kojovic et al. , 2013, 
McClelland et al. , 2014). 
The findings in children with complex idiopathic / genetic dystonia are worthy of particular 
comment.  These are children with unknown aetiology, no history of brain insult and normal 
cranial MRI, but in whom there was some additional abnormality such as mild learning 
difficulties. Previous studies of SEPs in dystonia have tended to exclude such patients and 
have focused on isolated idiopathic/genetic dystonia.  We included these children in our 
cohort as they represent an important part of our caseload and, as with the acquired dystonia 
patients, outcomes from GPi-DBS are more variable and harder to predict.  Within this 
complex idiopathic /genetic dystonia group, three children had abnormal CMCT and four had 
abnormal SEP.  The finding of an abnormal CMCT or SEP could provide further clues to the 
underlying pathophysiology in this group and we consider that these findings demonstrate the 
additional value of neurophysiology in their assessment, since their cranial imaging was 
normal.   
The relationship of neurophysiological parameters to outcome has important clinical 
implications and also promotes interesting scientific discussion regarding the underlying 
mechanisms. Theoretically a functioning CST is required for DBS to be effective, as, 
regardless of how pallidal DBS modulates brain network activity, an intact motor outflow 
pathway is needed. The current data support this concept:  no children with absent MEPs 
went forward for DBS, but a small number of children with prolonged CMCT (indicating 
some dysfunction of the CST) did receive DBS and the results indicate that these children 
are less likely to benefit from DBS. Clinical spasticity is associated with less benefit from 
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DBS,(Romito et al. , 2015) but CMCT can provide additional information about 
corticospinal tract function where examination findings do not reveal clear spasticity. 
The reason for an association between abnormal SEPs and response to DBS is not clear.   
The mechanisms by which DBS improves motor control are not yet understood, but it is 
becoming evident that stimulation of the GPi leads to widespread brain network changes:  
in idiopathic/genetic isolated dystonia DBS reduces cortical plasticity (Tisch et al. , 2007) 
and attenuates pathological low frequency oscillations between the basal ganglia and 
sensorimotor cortex (Barow et al. , 2014). Modulation of sensorimotor cortex by DBS has 
also been demonstrated with Deep Brain Stimulator Evoked Potentials (DBSEPs) 
(Bhanpuri et al. , 2014), likely to be mediated via pallido-thalamo-cortical projections 
(Tisch et al. , 2008). The importance of these projections is implied from the finding that 
the highest amplitude DBSEPs are evoked from those electrode contacts found clinically 
to produce the most benefit (Tisch et al. , 2008, Bhanpuri et al. , 2014), providing further 
evidence that modulation of the sensory network is relevant both to the mechanisms 
underlying dystonia and to the therapeutic effects of DBS. Our findings indicate that in 
some children with dystonia secondary to perinatal brain injury, there is abnormal 
development of the sensorimotor network as measured with SEPs. This could reflect 
dysfunction at the cortical level, thalamic level, thalamo-cortical pathways or a 
combination of these. If the network is mal-developed at the level of the sensorimotor 
cortex, then part of the very substrate that DBS is modulating may not be able to respond, 
leading to less benefit. If the abnormal SEP reflects thalamic or thalamo-cortical pathway 
dysfunction then this in turn may impede the transmission of the effects of pallidal 
neuromodulation via the pallido-thalamo-cortical pathway to the sensorimotor cortex, 
therefore “blocking” any effective improvement in motor control. Alternatively the 
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abnormal SEPs may simply indicate a greater severity of overall brain network 
disruption. Elucidation of the precise mechanisms requires further studies, but 
meanwhile, the present findings have potential clinical utility in guiding 
selection/stratification of children for DBS and counselling of families.   This is 
particularly relevant in children with acquired or idiopathic complex dystonia, in whom 
outcomes vary widely between individuals (Vidailhet et al. , 2009, Koy et al. , 2013, 
Olaya et al. , 2013).  
 
4.4 Relevance to clinical practice 
The service model adopted by our clinical service is described in Gimeno and Lin (2017). 
Clinical factors which tend to lead to the child being considered unsuitable for DBS 
include fixed contractures or a motor phenotype dominated by spasticity. In practical 
terms, up until this analysis, the finding of isolated CMCT or SEP abnormalities 
involving one or two limbs resulted in the communication to the parents and carers that 
DBS was unlikely to provide relief of symptoms in those limbs, whereas there remained 
the possibility of DBS efficacy in those limbs with normal neurophysiology findings. 
Conversely, in the context of normal CMCT and SEP results we have tended to be more 
optimistic about the potential outcome of DBS as this confirmed that these pathways 
were physiologically functional.  This approach was based upon theoretical arguments as 
outlined above, as there are no previously published data on this topic.  Overall, few 
patients with abnormal CMCT proceeded to DBS and those that did all had prolonged 
CMCT, rather than absent MEPs.  No patients with abnormal CMCT and SEP to all 
limbs went forward for DBS.   In addition to the neurophysiology findings, there were 
multiple other reasons why a child may not have proceeded to DBS, including findings 
  
 28 
from the multi-disciplinary clinical assessment and family preference, fears and 
expectations, even in “ideal” cases.  
 
The numbers of patients with abnormal CMCT/SEP and DBS outcome data are therefore 
rather small, and this necessitates caution in interpreting the results. Validation by further 
studies is desirable. Nevertheless, the outcomes for children with abnormal CMCT or 
SEP were consistently poor with median % change in BFMDRS-m score in these groups 
being -4% and -8% respectively (Figs 4 and 5). Moreover, no patients in the abnormal 
CMCT or SEP groups showed an improvement of more than 25% in BFMDRS-m.  The 
finding that neurophysiological evidence of abnormal motor or sensory pathway function 
is associated with less good outcome from DBS is consistent with both theoretical 
arguments and clinical findings (Romito et al., 2015). In addition, the consistency of the 
relationship for SEPs across two different outcome measures (one impairment based and 
the other function/goal-based) is notable.  Overall, we interpret these results as suggesting 
that abnormal neurophysiological parameters should be considered a relative contra-
indication to DBS.  
Although the presence of normal physiology appears to confer some advantage to the 
child potentially undergoing DBS for dystonia, there remains considerable variation in 
response even within this group and so the precise amount of benefit cannot yet be 
predicted. Indeed, when considered in terms of sensitivity and specificity, the specificity 
of an abnormal SEP and/or CMCT for detecting patients who will have a poor response 
to DBS appears to be considerably stronger than the sensitivity of the tests for identifying 
such patients (see Figures 4-5 and Supplementary Material).  Further predictive markers 
are therefore required. 
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The observation that a combination of abnormal CMCT and SEP was associated with an 
apparent deterioration in dystonia severity following DBS is of high importance.  The 
numbers are small (only four patients in this category), so again the results need cautious 
interpretation and ideally validation in future studies.  However, the specificity of a 
combined abnormal CMCT and SEP for a poor response to DBS was high and this effect 
was observed regardless of aetiological group or imaging findings. Particular caution may 
therefore be warranted in counselling these families about the potential role of DBS and 
consideration should be given to alternative therapies/ management strategies. Some 
benefits reported by families, such as improved comfort or pain control are not captured 
by standard assessment scales and one test alone does not necessarily rule out DBS for an 
individual patient. Each child undergoes a detailed multi-modal and multi-disciplinary 
assessment. However, the current findings suggest that neurophysiological markers make 
an important contribution to this assessment and can inform the stratification of children 
and counselling of families for precision DBS surgery.  Valuable additional information 
is gained, which is not available through imaging alone. Where one modality is 
unavailable, (e.g. due to contraindication to TMS) the CMCT or SEP findings alone each 
appear to have some clinical utility in helping to stratify patients for DBS.  The role of 
SEPs appears particularly important since these results correlated not only with change in 
dystonia severity (BFMDRS-m), but also with achievement of functional goals (COPM-
p).  However, it is preferable that both CMCT and SEP studies be performed for all limbs 
since the combined CMCT/SEP results were more informative than either of the 
individual tests in isolation.  
 
5. CONCLUSION 
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The current findings address the paucity of published neurophysiological data in children 
with dystonia and provide insight into the expanding spectrum of individuals with 
complex movement disorders being referred for DBS. Referrals for individuals with 
acquired dystonias are increasing. Outcomes in this group are more variable and a clear 
strategy is required for selecting children for neuromodulation and managing 
patient/family expectations regarding the potential benefit.  This is a single, retrospective 
study with small numbers in some sub-groups, which should be taken into account when 
interpreting the findings.  However, the apparent disadvantage to those with abnormal 
CMCT and SEP is striking.  We consider that the present data demonstrate the value of 
CMCT and SEPs in the selection process and would therefore recommend that these 
neurophysiological parameters be included alongside multi-disciplinary clinical, therapy 
and imaging assessments of potential candidates for DBS.  Further predictors are still 
required, emphasizing the need for continued multi-modal data collection and follow-up 
in order to arrive at the ideal of offering a personalized prognosis for each child referred 
for possible DBS neuromodulation for dystonia. 
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FIGURE LEGENDS 
 
Figure 1.  Example traces. A Normal upper limb SEPs from a 13 year-old child with 
isolated genetic (DYT1) dystonia.  B Upper limb SEPs from a 5 year old child with 
Dyskinetic Cerebral Palsy secondary to term HIE showing absent cortical response 
despite normal cervical responses.  C. Normal lower limb SEPs from same patient as A.  
D Lower limb SEPs from a 12 year old child with Dyskinetic Cerebral palsy secondary to 
prematurity (25 weeks) showing low-amplitude, poorly formed cortical waveform despite 
adequate peripheral and spinal responses. 
 
Figure 2 
A.  Distribution of abnormal neurophysiology results across aetiological groups.  
Bars show percentage of children in each aetiological group with one or more abnormal 
cortical SEP (grey) or CMCT result (red).  Note different denominators:  CMCT 
abnormal in 0/14 Genetic/Idiopathic Isolated, 3/19 Idiopathic Complex, 14/68 Acquired 
perinatal CP, 1/11 Acquired metabolic, 8/24 Acquired non-degenerative “Other” and 2/10 
Acquired degenerative.  SEP abnormal in 1/8 Genetic/Idiopathic Isolated, 4/13 Idiopathic 
Complex, 28/50 Acquired perinatal CP, 2/7 Acquired metabolic, 9/18 Acquired non-
degenerative “Other” and 4/4 Acquired degenerative patients.   
B.  Distribution of abnormal neurophysiology results across Clinical MRI 
Diagnostic Categories.  Bars show percentage of children in each imaging group with 
one or more abnormal cortical SEP (grey) or CMCT result (red).  Imaging abnormality in 
PVWM = Periventricular white matter, BG-GP = basal ganglia including globus pallidus, 
BG+Post WM = basal ganglia and posterior white matter.  Misc. (BG or Thal) = 
  
 33 
miscellaneous minor imaging abnormalities involving thalamus or basal ganglia other 
than globus pallidus.  Misc (non-BG/Thal) = miscellaneous minor imaging abnormalities 
not involving the basal ganglia or thalamus. 
 
Figure 3.  Flow charts showing numbers of children attending for each test (A = CMCT, 
B=SEP) and numbers proceeding to DBS.   
 
Figure 4.  Box and Whisker plots showing outcome from DBS measured as percentage 
change in BFMDRS-motor score at 1 year after surgery in relation to CMCT result. A) 
results for the whole group  B-E) sub-group analyses for B) Idiopathic/Genetic dystonia, 
C) Acquired dystonia, D) Normal cranial MRI, E) Abnormal cranial MRI. The p-values 
are calculated using Mann-Whitney tests.  Note different scales for C and E as 
improvements are generally smaller in these groups. 
 
Figure 5.  Box and Whisker plots showing outcome from DBS measured as percentage 
change in BFMDRS-motor score at 1 year after surgery in relation to SEP result. A) 
results for the whole group  B-E) sub-group analyses for B) Idiopathic/genetic dystonia, 
C) Acquired dystonia, D) Normal cranial MRI, E) Abnormal cranial MRI. The p-values 
are calculated using Mann-Whitney tests. Note different scales for C and E as 
improvements are generally smaller in these groups. 
 
Figure 6.  Box and Whisker plots showing outcome from DBS measured as percentage 
change in BFMDRS-motor score at 1 year after surgery in relation to Neurophysiology 
score. A) results for the whole group  B-E) sub-group analyses for B) Idiopathic/Genetic 
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dystonia, C) Acquired dystonia, D) Normal cranial MRI, E) Abnormal cranial MRI. 
Kruskal Wallis test shows significant difference across groups for A (p=0.002), C 
(p=0.018) and F (p=0.022).  The p-values shown on the figures are calculated using 
Mann-Whitney tests. Note different scales for C and E as improvements are generally 
smaller in these groups. 
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